en · de · es · fr · pt
melanotan-2-notes.peptides9000.com › Data › Background And Receptor Mechanism — Hands-On Walkthrough

Background And Receptor Mechanism — Hands-On Walkthrough

By Editorial Desk · published 2026-03-21 · last reviewed 2026-04-26 · Data

cyclic peptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2026-04-26. Anything still debated is marked as such rather than presented as settled.

Background and Receptor Mechanism

Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.

Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.

Handling, Storage, and Analytical Verification

Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.

Lyophilised melanotan-2 is supplied as a solid, which is more stable than a solution. The material is hygroscopic, so weighing is done quickly, in low humidity, with the container kept sealed. Reconstitution usually uses water for injection or bacteriostatic water, added down the wall of the vial to limit foaming. A reconstituted solution is held at 2 to 8 °C and kept away from light. Repeated freezing and thawing of the same vial is avoided because ice crystal formation and concentration effects degrade the peptide.

Reversed-phase high-performance liquid chromatography is the routine method for purity assessment. Peptides absorb near 214 nm because of the peptide bond, and a gradient of acetonitrile in water separates the intact peptide from deletion sequences, oxidised products, and earlier-eluting fragments at neutral pH. Electrospray ionisation mass spectrometry provides an orthogonal check: the measured mass must agree with the theoretical value. Amino acid analysis and peptide mapping confirm structure but are used less often. Reference standards remain scarce because the peptide is not described in any pharmacopoeia.

Melanotan-2 at a glance

PropertyValueNotes
Chemical classSynthetic cyclic heptapeptideAnalog of alpha-melanocyte-stimulating hormone
Primary receptor familyMelanocortin receptors MC1R through MC5RBinding is not subtype-selective
Development period1980sSynthesized during pigmentation and appetite research
Regulatory statusNot an approved medicineNo major regulator has authorized human use
Related compoundAfamelanotideLinear analog studied for photoprotection

Melanotan-2 Identity and Receptor Pharmacology

Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.

Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.

Related pages on this site

Storage, Verification and Regulatory Status

Freeze-dried melanotan-2 is normally kept as a desiccated powder at minus twenty degrees Celsius or lower, shielded from light and moisture. Peptides of this size degrade through hydrolysis, oxidation and deamidation, and each pathway accelerates as temperature and water activity rise. Repeated freeze-thaw cycles promote aggregation and loss of material, so aliquoting a stock solution before freezing is standard laboratory practice. Once dissolved, the solution is markedly less stable than the powder. In laboratory work, solutions are generally refrigerated and used within days rather than kept for months.

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or oxidised impurities. Mass spectrometry, most often coupled to liquid chromatography, confirms molecular mass and detects substitutions that chromatography alone may miss. Amino acid analysis and peptide mapping supply additional structural evidence, while nuclear magnetic resonance is reserved for full structural confirmation. Laboratories that examine samples sold online report wide variation in actual content, with some vials containing little or none of the labelled material.

Peptide Identity and Structural Background

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.

The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.

Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.

Reference notes

=== Mechanisms === Although the mechanisms by which BMAA causes motor neuron dysfunction and death are not entirely understood, current research suggests that there are multiple mechanisms of action. Acutely, BMAA can act as an excitotoxin on glutamate receptors, such as NMDA, calcium-dependent AMPA, and kainate receptors. The activation of the metabotropic glutamate receptor 5 is believed to induce oxidative stress in the neuron by depletion of glutathione. BMAA can be misincorporated into nascent proteins in place of L-serine, possibly causing protein misfolding and aggregation, both hallmarks of tangle diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), progressive supranuclear palsy (PSP), and Lewy body disease. In vitro research has shown that protein association of BMAA may be inhibited in the presence of excess L-serine.

== Incompressible flow equation == In most flows of liquids, and of gases at low Mach number, the density of a fluid parcel can be considered to be constant, regardless of pressure variations in the flow. Therefore, the fluid can be considered to be incompressible, and these flows are called incompressible flows. Bernoulli performed his experiments on liquids, so his equation in its original form is valid only for incompressible flow. A common form of Bernoulli's equation is:

One tablet contains the first mention of the name of the city of London, more than a half a century earlier than was previously thought to be the first naming of London, in the Annals of Tacitus. Another tablet said that Verulamium supplied London with provisions and not vice versa as had been thought originally. All of these legal documents were in the wax tablets, however the ink leaf tablets are believed to have contained more short-lived correspondences.

Works by or about Frederick Banting at the Internet Archive Banting House National Historic Site (Archived January 17, 2021, at the Wayback Machine) Frederick Banting on Nobelprize.org including the Nobel Lecture on September 15, 1925, "Diabetes and Insulin" Ontario Plaques – The Discovery of Insulin (Archived December 22, 2015, at the Wayback Machine) CBC Digital Archives – Chasing a Cure for Diabetes Simcoe County Archives – "Sir Frederick Banting" Famous Canadian Physicians: Sir Frederick Banting at Library and Archives Canada World Diabetes Day on Banting's Birthday, November 14 1928 A.Y. Jackson and Frederick Banting – NWT Historical Timeline, Prince of Wales Northern Heritage Centre Frederick Banting Papers, Thomas Fisher Rare Book Library Archived March 14, 2012, at the Wayback Machine The Discovery and Early Development of Insulin Digital Collection, Toronto

== Legal Issues == On 2 May 2018, he was charged with seven counts of drug trafficking and possession. He was released on $20,000 bail to appear in court at a later date. He was later cleared of trafficking but convicted of possession.

Sources: en.wikipedia.org

Notes from published material

== External links == Latin American Crime and US Relations from the Dean Peter Krogh Foreign Affairs Digital Archives Latin America's Drug War Evolution Farmers Losing Columbia's Drug War The Cocaine Industry in Bolivia-Its Impact on the Peasantry Coca Production Makes a Comeback in Peru

== Pathovars == Following ribotype analysis, incorporation of several pathovars of P. syringae into other species was proposed (see P. amygdali, 'P. tomato', P. coronafaciens, P. avellanae, 'P. helianthi', P. tremae, P. cannabina, and P. viridiflava). According to this schema, the remaining pathovars are:

In June 2023, Collins attended the Animal Ball at Lancaster House in support of Elephant Family, a charity dedicated to protecting the Asian elephant from extinction. During the event, she met Charles III and Queen Camilla, with whom she discussed her elephant sculptures she purchased in support of the organisation, before inviting them to go on a safari with her. Collins has been a long-time supporter of Camp Beagle, a protest camp set up by animal rights activists who campaign for the closure of MBR Acres, a breeding facility for beagles used in laboratory research. In February 2024, she gave a speech at the rally outside of the Houses of Parliament where she encouraged people to "keep making noise" about MBR Acres and vowed to "Save the Beagles" by ensuring its closure, prior to attending the parliamentary debate to ban toxicology tests on animals. In April 2024, Collins became an ambassador for "Bark for Our Parks", a campaign for the charity Fields in Trust which protects parks and green spaces. The campaign encouraged owners and their dogs to embark on walking 50km or 100km as part of a fundraiser. Speaking of the campaign, Collins said she was "so excited to be welcomed into the Fields in Trust family as a Bark For Our Parks ambassador", and added that "the highlight of [her dog] Blue's day, and often her own was exploring their local parks and green spaces, so [she was] really happy that [she got] to be a part of this wonderful initiative helping to make sure our walkies will be here forever.

=== Other === Benzodiazepines, such as clonazepam, are sometimes used for the treatment of mania or acute psychosis-induced aggression. In this context, benzodiazepines are given either alone or in combination with other first-line drugs such as lithium, haloperidol, or risperidone. Studies vary in confidence as to whether current evidence supports the use of clonazepam for treatment of acute mania. The effectiveness of taking benzodiazepines along with antipsychotic medication is unknown, as is whether benzodiazepines are more effective than antipsychotics when urgent sedation is required. Hyperekplexia Many forms of parasomnia and other sleep disorders are treated with clonazepam. It is not effective for preventing migraines. Clonazepam is also used topically to treat burning mouth syndrome via its action on the ion channel TRPM8.

Sources: en.wikipedia.org

Further detail

Mechanism The reaction of tetrazines with trans-cyclooctenes is a highly specific biorthogonal reaction recognized for its rapid reaction rates, compatibility with physiological environments, and its metal-free characteristics. Commonly referred to as tetrazine ligation, the reaction was initially reported in 2008 and has since become a widely adopted bioorthogonal chemistry tool in both in vivo and in vitro studies. The tetrazine ligation is a specific type of inverse electron demand Diels-Alder (shown in the second mechanism in Figure 13) (iEDDA) [4+2] cycloaddition. The mechanism involves an electron-deficient tetrazine, typically a substituted 3,6-diaryl-s-tetrazine functioning as the diene and an electron-rich strained alkene, typically a trans-cyclooctene (TCO) compound, serving as the dienophile (shown in Figure 14). Trans-cyclooctenes have a high strain energy of 17.9 kcal/mol due to their non-planar double bond, making it very reactive and a strong dienophile. Following the initial iEDDA, a retro-Diels-Alder (shown in the last mechanism in Figure 13) reaction occurs, resulting in the expulsion of nitrogen gas (N2), driving the reaction forward. This promotes the irreversible nature of the reaction, which enhances its suitability for bio-labeling applications. This reaction has fast reactivity at low concentrations, with second order rate constants ranging from 1–106 M−1 s−1 depending on the specific tetrazine and TCO pair.

Bernoulli's principle is a concept in fluid dynamics that relates pressure, speed and height. For example, for a fluid flowing horizontally, Bernoulli's principle states that an increase in the speed occurs simultaneously with a decrease in pressure. The principle is named after the Swiss mathematician and physicist Daniel Bernoulli, who published it in his book Hydrodynamica in 1738. Although Bernoulli deduced that pressure decreases when the flow speed increases, it was Leonhard Euler in 1752 who derived Bernoulli's equation in its usual form. Bernoulli's principle can be derived directly from Isaac Newton's second law of motion. When a small volume of fluid is flowing horizontally from a region of high pressure to a region of low pressure, there is more pressure from behind than in front. This gives a net force on the volume, accelerating it along the streamline. If the pressure is decreasing along the streamline, the fluid is accelerated and the speed increases. Thus the decrease of pressure is the cause of a higher speed. Similarly, if the pressure is increasing, the speed decreases. Bernoulli's principle can also be derived from the principle of conservation of energy. In a steady fluid flow the total of all forms of energy is conserved. This requires that the sum of kinetic energy, potential energy and internal energy remains constant. Thus an increase in the kinetic energy of the fluid occurs with a simultaneous decrease in its potential energy and internal energy.

== Other uses == HMS Vesta, a schooner of the Royal Navy IF Vesta, sports club in Uppsala, Sweden established in 1911 SS Vesta (1853–1875), a French iron screw steamer Vesta (name), feminine given name Vesta Rowing Club (founded 1870), a rowing club based in London, England Vesta Battery Corporation (1897–1964), an automobile battery company

Sources: en.wikipedia.org

Frequently asked questions

Is melanotan II an approved medication?

No regulator in a major market has approved it for human use. It appears in research settings and in products marketed outside pharmacy channels. Legal status for personal possession varies by country.

How does it differ from afamelanotide?

Afamelanotide is a linear analog that has received approval in some jurisdictions for a specific photoprotection indication. Melanotan II is cyclic and less selective across melanocortin receptors. The two are related but are not interchangeable in regulatory or clinical terms.

Why does receptor selectivity matter?

A compound that activates several receptor subtypes may produce effects beyond pigmentation. Selectivity influences which tissues respond and shapes the side-effect profile described in reports. Designing subtype-selective analogs is a stated goal of melanocortin research.

Why are freeze-dried peptides kept cold?

Low temperature slows hydrolysis and oxidation, the two main routes by which the peptide backbone and side chains are modified. A lyophilised powder stored at −20 °C is more stable than one kept at room temperature, and once the material is dissolved the degradation rate rises, making refrigeration more important.

Network